 | • レポートコード：QYR9NV18215 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、非小細胞肺がん薬の世界市場について調査・分析し、非小細胞肺がん薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（生物製剤、小分子標的療法、化学療法、その他）、用途別（肺腺がん、扁平上皮肺がん、大細胞肺がん）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の非小細胞肺がん薬市場動向 ・主要企業別マーケットシェア ・非小細胞肺がん薬の種類別市場規模2014-2019 （生物製剤、小分子標的療法、化学療法、その他） ・非小細胞肺がん薬の用途別市場規模2014-2019 （肺腺がん、扁平上皮肺がん、大細胞肺がん） ・非小細胞肺がん薬の北米市場：主要企業・種類別/用途別市場規模 ・非小細胞肺がん薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・非小細胞肺がん薬の中国市場：主要企業・種類別/用途別市場規模 ・非小細胞肺がん薬の日本国内市場：主要企業・種類別/用途別市場規模 ・非小細胞肺がん薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・非小細胞肺がん薬のインド市場：主要企業・種類別/用途別市場規模 ・非小細胞肺がん薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （AstraZeneca、Bristol-Myers Squibb Company、Eli Lilly and Company、F. Hoffmann-La Roche Ltd、Merck & Co., Inc.） ・非小細胞肺がん薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drugs market growth during the forecast period. With the increase in the prevalence of lung cancer, the need for a strong pipeline of disease-modifying drugs is also increasing.
In 2018, the global Non-small Cell Lung Cancer Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Non-small Cell Lung Cancer Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-small Cell Lung Cancer Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
AstraZeneca
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Merck & Co., Inc.
…
Market segment by Type, the product can be split into
Biologics
Small Molecule Targeted Therapy
Chemotherapy
Other
Market segment by Application, split into
Lung Adenocarcinoma
Squamous Cell Lung Carcinoma
Large-cell Lung Carcinoma
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Non-small Cell Lung Cancer Drugs status, future forecast, growth opportunity, key market and key players.
To present the Non-small Cell Lung Cancer Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Non-small Cell Lung Cancer Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Biologics
1.4.3 Small Molecule Targeted Therapy
1.4.4 Chemotherapy
1.4.5 Other
1.5 Market by Application
1.5.1 Global Non-small Cell Lung Cancer Drugs Market Share by Application (2019-2025)
1.5.2 Lung Adenocarcinoma
1.5.3 Squamous Cell Lung Carcinoma
1.5.4 Large-cell Lung Carcinoma
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Non-small Cell Lung Cancer Drugs Market Size
2.2 Non-small Cell Lung Cancer Drugs Growth Trends by Regions
2.2.1 Non-small Cell Lung Cancer Drugs Market Size by Regions (2019-2025)
2.2.2 Non-small Cell Lung Cancer Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Non-small Cell Lung Cancer Drugs Market Size by by Players
3.1.1 Global Non-small Cell Lung Cancer Drugs Revenue by by Players (2014-2019)
3.1.2 Global Non-small Cell Lung Cancer Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Non-small Cell Lung Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Non-small Cell Lung Cancer Drugs Key Players Head office and Area Served
3.3 Key Players Non-small Cell Lung Cancer Drugs Product/Solution/Service
3.4 Date of Enter into Non-small Cell Lung Cancer Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Non-small Cell Lung Cancer Drugs Market Size by Type (2014-2019)
4.2 Global Non-small Cell Lung Cancer Drugs Market Size by Application (2014-2019)
5 North America
5.1 North America Non-small Cell Lung Cancer Drugs Market Size (2014-2019)
5.2 Non-small Cell Lung Cancer Drugs Key Players in North America
5.3 North America Non-small Cell Lung Cancer Drugs Market Size by Type
5.4 North America Non-small Cell Lung Cancer Drugs Market Size by Application
6 Europe
6.1 Europe Non-small Cell Lung Cancer Drugs Market Size (2014-2019)
6.2 Non-small Cell Lung Cancer Drugs Key Players in Europe
6.3 Europe Non-small Cell Lung Cancer Drugs Market Size by Type
6.4 Europe Non-small Cell Lung Cancer Drugs Market Size by Application
7 China
7.1 China Non-small Cell Lung Cancer Drugs Market Size (2014-2019)
7.2 Non-small Cell Lung Cancer Drugs Key Players in China
7.3 China Non-small Cell Lung Cancer Drugs Market Size by Type
7.4 China Non-small Cell Lung Cancer Drugs Market Size by Application
8 Japan
8.1 Japan Non-small Cell Lung Cancer Drugs Market Size (2014-2019)
8.2 Non-small Cell Lung Cancer Drugs Key Players in Japan
8.3 Japan Non-small Cell Lung Cancer Drugs Market Size by Type
8.4 Japan Non-small Cell Lung Cancer Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Non-small Cell Lung Cancer Drugs Market Size (2014-2019)
9.2 Non-small Cell Lung Cancer Drugs Key Players in Southeast Asia
9.3 Southeast Asia Non-small Cell Lung Cancer Drugs Market Size by Type
9.4 Southeast Asia Non-small Cell Lung Cancer Drugs Market Size by Application
10 India
10.1 India Non-small Cell Lung Cancer Drugs Market Size (2014-2019)
10.2 Non-small Cell Lung Cancer Drugs Key Players in India
10.3 India Non-small Cell Lung Cancer Drugs Market Size by Type
10.4 India Non-small Cell Lung Cancer Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Non-small Cell Lung Cancer Drugs Market Size (2014-2019)
11.2 Non-small Cell Lung Cancer Drugs Key Players in Central & South America
11.3 Central & South America Non-small Cell Lung Cancer Drugs Market Size by Type
11.4 Central & South America Non-small Cell Lung Cancer Drugs Market Size by Application
12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Non-small Cell Lung Cancer Drugs Introduction
12.1.4 AstraZeneca Revenue in Non-small Cell Lung Cancer Drugs Business (2014-2019))
12.1.5 AstraZeneca Recent Development
12.2 Bristol-Myers Squibb Company
12.2.1 Bristol-Myers Squibb Company Company Details
12.2.2 Company Description and Business Overview
12.2.3 Non-small Cell Lung Cancer Drugs Introduction
12.2.4 Bristol-Myers Squibb Company Revenue in Non-small Cell Lung Cancer Drugs Business (2014-2019)
12.2.5 Bristol-Myers Squibb Company Recent Development
12.3 Eli Lilly and Company
12.3.1 Eli Lilly and Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Non-small Cell Lung Cancer Drugs Introduction
12.3.4 Eli Lilly and Company Revenue in Non-small Cell Lung Cancer Drugs Business (2014-2019)
12.3.5 Eli Lilly and Company Recent Development
12.4 F. Hoffmann-La Roche Ltd
12.4.1 F. Hoffmann-La Roche Ltd Company Details
12.4.2 Company Description and Business Overview
12.4.3 Non-small Cell Lung Cancer Drugs Introduction
12.4.4 F. Hoffmann-La Roche Ltd Revenue in Non-small Cell Lung Cancer Drugs Business (2014-2019)
12.4.5 F. Hoffmann-La Roche Ltd Recent Development
12.5 Merck & Co., Inc.
12.5.1 Merck & Co., Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Non-small Cell Lung Cancer Drugs Introduction
12.5.4 Merck & Co., Inc. Revenue in Non-small Cell Lung Cancer Drugs Business (2014-2019)
12.5.5 Merck & Co., Inc. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Non-small Cell Lung Cancer Drugs Key Market Segments
Table Key Players Non-small Cell Lung Cancer Drugs Covered
Table Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Biologics Figures
Table Key Players of Biologics
Figuer Small Molecule Targeted Therapy Figures
Table Key Players of Small Molecule Targeted Therapy
Figuer Chemotherapy Figures
Table Key Players of Chemotherapy
Figuer Other Figures
Table Key Players of Other
Table Global Non-small Cell Lung Cancer Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Non-small Cell Lung Cancer Drugs Market Share by Application in 2018 & 2025
Figure Lung Adenocarcinoma Case Studies
Figure Squamous Cell Lung Carcinoma Case Studies
Figure Large-cell Lung Carcinoma Case Studies
Figure Non-small Cell Lung Cancer Drugs Report Years Considered
Figure Global Non-small Cell Lung Cancer Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Non-small Cell Lung Cancer Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Non-small Cell Lung Cancer Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Non-small Cell Lung Cancer Drugs Market Share by Regions 2014-2019
Figure Global Non-small Cell Lung Cancer Drugs Market Share by Regions 2014-2019
Figure Global Non-small Cell Lung Cancer Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Non-small Cell Lung Cancer Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Non-small Cell Lung Cancer Drugs Market Share by by Players (2014-2019)
Figure Global Non-small Cell Lung Cancer Drugs Market Share by by Players in 2018
Table Global Non-small Cell Lung Cancer Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Non-small Cell Lung Cancer Drugs Product/Solution/Service
Table Date of Enter into Non-small Cell Lung Cancer Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Non-small Cell Lung Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Non-small Cell Lung Cancer Drugs Market Size Share by Type (2014-2019)
Figure Global Non-small Cell Lung Cancer Drugs Market Size Market Share by Type (2014-2019)
Table Global Non-small Cell Lung Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Non-small Cell Lung Cancer Drugs Market Size Share by Application (2014-2019)
Figure Global Non-small Cell Lung Cancer Drugs Market Size Market Share by Application (2014-2019)
Figure Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Application in 2018
Figure North America Non-small Cell Lung Cancer Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Non-small Cell Lung Cancer Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Non-small Cell Lung Cancer Drugs Market Share (2018-2019)
Table North America Non-small Cell Lung Cancer Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Non-small Cell Lung Cancer Drugs Market Share by Type 2014-2019
Table North America Non-small Cell Lung Cancer Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Non-small Cell Lung Cancer Drugs Market Share by Application 2014-2019
Figure Europe Non-small Cell Lung Cancer Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Non-small Cell Lung Cancer Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Non-small Cell Lung Cancer Drugs Market Share (2018-2019)
Table Europe Non-small Cell Lung Cancer Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Non-small Cell Lung Cancer Drugs Market Share by Type 2014-2019
Table Europe Non-small Cell Lung Cancer Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Non-small Cell Lung Cancer Drugs Market Share by Application 2014-2019
Figure China Non-small Cell Lung Cancer Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Non-small Cell Lung Cancer Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Non-small Cell Lung Cancer Drugs Market Share (2018-2019)
Table China Non-small Cell Lung Cancer Drugs Market Size by Type 2014-2019 (Million US$)
Table China Non-small Cell Lung Cancer Drugs Market Share by Type 2014-2019
Table China Non-small Cell Lung Cancer Drugs Market Size by Application 2014-2019 (Million US$)
Table China Non-small Cell Lung Cancer Drugs Market Share by Application 2014-2019
Figure Japan Non-small Cell Lung Cancer Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Non-small Cell Lung Cancer Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Non-small Cell Lung Cancer Drugs Market Share (2018-2019)
Table Japan Non-small Cell Lung Cancer Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Non-small Cell Lung Cancer Drugs Market Share by Type 2014-2019
Table Japan Non-small Cell Lung Cancer Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Non-small Cell Lung Cancer Drugs Market Share by Application 2014-2019
Figure Southeast Asia Non-small Cell Lung Cancer Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Non-small Cell Lung Cancer Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Non-small Cell Lung Cancer Drugs Market Share (2018-2019)
Table Southeast Asia Non-small Cell Lung Cancer Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Non-small Cell Lung Cancer Drugs Market Share by Type 2014-2019
Table Southeast Asia Non-small Cell Lung Cancer Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Non-small Cell Lung Cancer Drugs Market Share by Application 2014-2019
Figure India Non-small Cell Lung Cancer Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Non-small Cell Lung Cancer Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Non-small Cell Lung Cancer Drugs Market Share (2018-2019)
Table India Non-small Cell Lung Cancer Drugs Market Size by Type 2014-2019 (Million US$)
Table India Non-small Cell Lung Cancer Drugs Market Share by Type 2014-2019
Table India Non-small Cell Lung Cancer Drugs Market Size by Application 2014-2019 (Million US$)
Table India Non-small Cell Lung Cancer Drugs Market Share by Application 2014-2019
Figure Central & South America Non-small Cell Lung Cancer Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Non-small Cell Lung Cancer Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Non-small Cell Lung Cancer Drugs Market Share (2018-2019)
Table Central & South America Non-small Cell Lung Cancer Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Non-small Cell Lung Cancer Drugs Market Share by Type 2014-2019
Table Central & South America Non-small Cell Lung Cancer Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Non-small Cell Lung Cancer Drugs Market Share by Application 2014-2019
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Non-small Cell Lung Cancer Drugs Business 2014-2019 (Million US$)
Figure AstraZeneca Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Non-small Cell Lung Cancer Drugs Business 2014-2019 (Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Non-small Cell Lung Cancer Drugs Business 2014-2019 (Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table F. Hoffmann-La Roche Ltd Company Details
Table F. Hoffmann-La Roche Ltd Revenue in Non-small Cell Lung Cancer Drugs Business 2014-2019 (Million US$)
Figure F. Hoffmann-La Roche Ltd Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2014-2019)
Table F. Hoffmann-La Roche Ltd Recent Development
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Revenue in Non-small Cell Lung Cancer Drugs Business 2014-2019 (Million US$)
Figure Merck & Co., Inc. Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2014-2019)
Table Merck & Co., Inc. Recent Development
Table Global Non-small Cell Lung Cancer Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Non-small Cell Lung Cancer Drugs Market Size Share by Regions (2019-2025)
Figure Global Non-small Cell Lung Cancer Drugs Market Size Share by Regions in 2025
Figure North America Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Non-small Cell Lung Cancer Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Non-small Cell Lung Cancer Drugs Market Size by Product (2019-2025)
Figure Global Non-small Cell Lung Cancer Drugs Market Size by Product in 2025
Table Global Non-small Cell Lung Cancer Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Non-small Cell Lung Cancer Drugs Market Size by Application (2019-2025)
Figure Global Non-small Cell Lung Cancer Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
非小細胞肺がん薬のグローバル市場：規模・現状・予測2019-2025 Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drugs…- 肺がん液体生検の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer. Scope of the Report: This report studies the Lung Cancer Liquid Biopsy market status and outlook of Global and major regions, from ang…
- 腎細胞がん治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Renal cell carcinoma (RCC) is a kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the very small tubes in the kidney that transport primary urine. RCC is the most common type of kidney cancer in adults, responsible for approximately 90–95% of cases.The drug is …
- 肺がん手術の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Lung adenocarcinoma is a type of lung cancer and belongs to non-small cell carcinoma. Scope of the Report: This report focuses on the Lung Cancer Surgery in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market …
- 線維形成性小円形細胞腫瘍の治療のグローバル市場：規模・現状・予測2019-2025 Desmoplastic Small Round Cell Tumor (DSRCT) refers to a rare kind of aggressive soft tissue cancer that usually begins at abdomen and hematogenously disseminates to the liver.In 2018, the global Desmoplastic Small Round Cell Tumor Treatment market size was xx million US$ and it is expected to reach …